tradingkey.logo

Cosmos Health Inc

COSM
0.425USD
-0.024-5.43%
收盘 02/09, 16:00美东报价延迟15分钟
42.02K总市值
亏损市盈率 TTM

Cosmos Health Inc

0.425
-0.024-5.43%

关于 Cosmos Health Inc 公司

Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.

Cosmos Health Inc简介

公司代码COSM
公司名称Cosmos Health Inc
上市日期May 19, 2010
CEOSiokas (Grigorios)
员工数量149
证券类型Ordinary Share
年结日May 19
公司地址5 Agiou Georgiou, Pilea
城市THESSALONIKI
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Greece
邮编554 38
电话303125363102
网址https://www.cosmosholdingsinc.com/
公司代码COSM
上市日期May 19, 2010
CEOSiokas (Grigorios)

Cosmos Health Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
8.18M
+1465349.00%
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
15.00K
--
Mr. Nikos Bardakis
Mr. Nikos Bardakis
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Theodoros C. Karkantzos
Mr. Theodoros C. Karkantzos
Director
Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
8.18M
+1465349.00%
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
15.00K
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
Greece
16.39M
95.77%
UK
512.54K
3.00%
United Arab Emirates (
118.40K
0.69%
Cyprus
56.93K
0.33%
Albania
23.41K
0.14%
其他
11.89K
0.07%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 1月2日 周五
更新时间: 1月2日 周五
持股股东
股东类型
持股股东
持股股东
占比
Siokas (Grigorios)
23.43%
Bovopoulos (Andreas D)
4.16%
Terzis (Georgios)
2.08%
BlackRock Institutional Trust Company, N.A.
0.77%
The Vanguard Group, Inc.
0.68%
其他
68.88%
持股股东
持股股东
占比
Siokas (Grigorios)
23.43%
Bovopoulos (Andreas D)
4.16%
Terzis (Georgios)
2.08%
BlackRock Institutional Trust Company, N.A.
0.77%
The Vanguard Group, Inc.
0.68%
其他
68.88%
股东类型
持股股东
占比
Individual Investor
30.10%
Investment Advisor
1.56%
Hedge Fund
0.91%
Investment Advisor/Hedge Fund
0.70%
Venture Capital
0.19%
Research Firm
0.12%
Bank and Trust
0.02%
其他
66.40%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
39
1.22M
3.49%
-1.83M
2025Q3
40
1.21M
10.09%
+200.56K
2025Q2
40
1.01M
10.29%
-1.71M
2025Q1
38
2.72M
7.86%
+891.30K
2024Q4
38
1.62M
11.55%
-779.82K
2024Q3
39
2.40M
4.16%
+1.81M
2024Q2
40
591.35K
13.72%
-13.70K
2024Q1
40
605.05K
14.49%
-1.85M
2023Q4
39
1.97M
8.60%
+1.22M
2023Q3
36
746.56K
8.56%
-123.02K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Siokas (Grigorios)
6.72M
19.23%
+256.79K
+3.98%
Dec 19, 2025
Bovopoulos (Andreas D)
1.45M
4.16%
-427.73K
-22.74%
Aug 13, 2025
Terzis (Georgios)
727.26K
2.08%
--
--
Aug 01, 2025
BlackRock Institutional Trust Company, N.A.
267.80K
0.77%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
235.74K
0.68%
+100.91K
+74.84%
Sep 30, 2025
Citadel Advisors LLC
225.51K
0.65%
+128.78K
+133.13%
Sep 30, 2025
Geode Capital Management, L.L.C.
198.68K
0.57%
+7.12K
+3.72%
Sep 30, 2025
Renaissance Technologies LLC
92.80K
0.27%
+92.80K
--
Sep 30, 2025
XTX Markets LLC
65.49K
0.19%
+28.79K
+78.45%
Sep 30, 2025
Bardakis (Nikolaos)
45.00K
0.13%
--
--
Aug 01, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
公告日期
除权除息日
类型
比率
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
KeyAI